MABVAX THERAPEUTICS HOLDINGS, INC. - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - June 23, 2016

Attached files

file filename
EX-5.1 - OPINION OF SICHENZIA ROSS FRIEDMAN FERENCE LLP, AS TO THE LEGALITY OF THE SECURITIES BEING REGISTERED - MABVAX THERAPEUTICS HOLDINGS, INC.ex5-1.htm
EX-4.14 - FORM OF UNDERWRITER WARRANT - MABVAX THERAPEUTICS HOLDINGS, INC.ex4-14.htm
EX-4.13 - FORM OF WARRANT - MABVAX THERAPEUTICS HOLDINGS, INC.ex4-13.htm
EX-1.1 - UNDERWRITING AGREEMENT - MABVAX THERAPEUTICS HOLDINGS, INC.ex1-1.htm
S-1/A - AMENDMENT NO. 2 TO FORM S-1 - MABVAX THERAPEUTICS HOLDINGS, INC.mbvxs1a_am2jun-2016.htm
Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm
 
We consent to the inclusion in this Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-211421) of MabVax Therapeutics Holdings, Inc. of our report, which includes an explanatory paragraph relating to MabVax Therapeutics Holdings, Inc.'s ability to continue as a going concern, dated March 14, 2016, related to our audits of the consolidated financial statements of MabVax Therapeutics Holdings, Inc., as of December 31, 2015 and 2014 and for the years then ended.  We also consent to the reference to our Firm under the caption “Experts”.
 
/s/ CohnReznick LLP
San Diego, California
June 23, 2016

Stock widget

Investing forum

MABVAX THERAPEUTICS HOLDINGS, INC. Reports